BNGO vs DEO · rev $14.9M vs P/E 16, $55.86B cap
Bionano Genomics Inc (BNGO) versus Diageo PLC ADR (DEO) — a side-by-side from cached financials, not a winner call.
Bionano Genomics Inc (BNGO) is a medical instruments & supplies company listed on US.
Diageo PLC ADR (DEO) is a beverages - wineries & distilleries company listed on US.
Latest reported BNGO revenue for 2026-06-30 was $14.9M. Net income was -$15.7M. BNGO currently screens at market cap $13.4M.
DEO does not have a complete income-statement cache yet.
BNGO currently screens at market cap $13.4M. DEO currently screens at market cap $55.86B and trailing P/E 15.6.
Not investment advice. Open the BNGO and DEO stock pages for the full models.
Not investment advice.